To amend the Federal Food, Drug, and Cosmetic Act to restrict the authority of the Food and Drug Administration to issue clinical holds regarding investigational drugs or to deny patients expanded access to such drugs.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Indiana's 6th congressional district. Republican.
Last Updated: Feb 16, 2000
Length: 4 pages
106th Congress, 1999–2000
This bill was introduced on February 16, 2000, in a previous session of Congress, but was not enacted.
Feb 16, 2000
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 3677 (106th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 106th Congress, which met from Jan 6, 1999 to Dec 15, 2000. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 3677 — 106th Congress: Thomas Navarro FDA Patient Rights Act. Retrieved from https://www.govtrack.us/congress/bills/106/hr3677
“H.R. 3677 — 106th Congress: Thomas Navarro FDA Patient Rights Act.” www.GovTrack.us. 2000. October 14, 2019 <https://www.govtrack.us/congress/bills/106/hr3677>
Thomas Navarro FDA Patient Rights Act, H.R. 3677, 106th Cong. (2000).
|title=H.R. 3677 (106th)
|accessdate=October 14, 2019
|author=106th Congress (2000)
|date=February 16, 2000
|quote=Thomas Navarro FDA Patient Rights Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.